 |
|
|
| |
Doravirine (MK-1439): A Novel HIV-1 NNRTI With a Distinct Resistance Profile
|
| |
| |
Reported by Jules Levin
International Workshop on Antiviral Drug Resistance
June 3-7 2014, Berlin, Germany
Ming-Tain Lai,1 Meizhen Feng,1 Nancy Sachs,2 Min Xu,2 Jay Grobler,1 Xia Xu,3 Charlotte Harvey,4 Hedy Teppler,4 Daria J. Hazuda,1 Michael D. Miller1
1Department of Antiviral Research, 2Department of In Vitro Pharmacology, 3Department of Late Development Statistics, 4Department of Global Clinical Development, Merck & Co. Inc., Whitehouse Station, NJ, USA
|
| |
|
|
|
|
|
